SPDR S&P Biotech ETF $XBI Stock Position Decreased by K.J. Harrison & Partners Inc

K.J. Harrison & Partners Inc cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 94.6% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,720 shares of the exchange traded fund’s stock after selling 30,160 shares during the quarter. K.J. Harrison & Partners Inc’s holdings in SPDR S&P Biotech ETF were worth $220,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Avoro Capital Advisors LLC bought a new stake in SPDR S&P Biotech ETF in the fourth quarter worth $256,053,000. Wells Fargo & Company MN raised its holdings in SPDR S&P Biotech ETF by 75.7% during the fourth quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after buying an additional 1,536,122 shares in the last quarter. OMERS ADMINISTRATION Corp lifted its position in shares of SPDR S&P Biotech ETF by 42,425.2% in the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock worth $145,147,000 after buying an additional 1,187,907 shares during the last quarter. Morgan Stanley lifted its position in shares of SPDR S&P Biotech ETF by 8.3% in the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after buying an additional 882,718 shares during the last quarter. Finally, Assetmark Inc. lifted its position in shares of SPDR S&P Biotech ETF by 1,042,265.6% in the fourth quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock worth $77,528,000 after buying an additional 635,782 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

XBI opened at $160.46 on Monday. The company has a market cap of $10.85 billion, a PE ratio of 11.47 and a beta of 0.82. The stock has a 50-day moving average of $137.41 and a 200-day moving average of $130.02. SPDR S&P Biotech ETF has a 52-week low of $83.02 and a 52-week high of $160.82.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.